Fresenius Medical Care AG - SPONSORED ADR (FMS)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
33.5M
Holdings value Q3 2024
$713M
Value change Q3 2024
+$47M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
161
Number of buys Q3 2024
76
Number of sells Q3 2024
-66
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 33.5M $713M +$47M $21.30 161
2024 Q2 31.3M $598M -$36.5M $19.09 164
2024 Q1 33.2M $640M -$369K $19.28 166
2023 Q4 33.1M $690M -$1.43M $20.83 157
2023 Q3 33.1M $711M -$24.6M $21.54 142
2023 Q2 34.1M $816M -$113M $23.93 138
2023 Q1 38.9M $828M -$106M $21.26 144
2022 Q4 44.1M $721M +$191M $16.34 148
2022 Q3 32.6M $458M -$40.5M $14.04 134
2022 Q2 32.2M $804M +$52.3M $24.94 154
2022 Q1 30.6M $1.03B +$97.9M $33.68 172
2021 Q4 27.7M $899M +$54.2M $32.46 166
2021 Q3 25.9M $905M +$191M $34.97 149
2021 Q2 20.4M $846M +$44.5M $41.57 168
2021 Q1 19.3M $714M +$321M $36.88 161
2020 Q4 10.5M $435M +$61.9M $41.56 166
2020 Q3 9.06M $385M +$304K $42.48 172
2020 Q2 9.27M $401M +$17.6M $43.28 167
2020 Q1 8.97M $295M -$29.8M $32.80 161
2019 Q4 9.68M $357M +$46.1M $36.83 159
2019 Q3 8.49M $285M -$16.8M $33.59 150
2019 Q2 8.95M $351M -$425K $39.28 160
2019 Q1 8.94M $362M -$95.8M $40.53 172
2018 Q4 11.4M $369M -$138M $32.39 178
2018 Q3 14.7M $756M -$5.91M $51.42 211
2018 Q2 15.1M $763M -$7.19M $50.35 216
2018 Q1 15.3M $781M +$24.2M $51.08 223
2017 Q4 14.8M $778M -$203M $52.55 215
2017 Q3 18.6M $911M +$124M $48.89 202
2017 Q2 15.4M $745M -$23.3M $48.33 183
2017 Q1 16.5M $696M +$35.9M $42.13 180
2016 Q4 15.7M $664M +$4.53M $42.21 181
2016 Q3 15.5M $679M +$53.8M $43.77 177
2016 Q2 14.3M $622M +$21.9M $43.57 166
2016 Q1 13.8M $607M +$162M $44.08 168
2015 Q4 10.1M $423M -$43.9M $41.84 143
2015 Q3 11.2M $438M +$5.63M $39.01 135
2015 Q2 11.4M $473M -$15.5M $41.59 139
2015 Q1 11.8M $488M -$12.8M $41.45 137
2014 Q4 12.2M $453M -$28.4M $37.14 138
2014 Q3 12.9M $449M -$22.3M $34.70 126
2014 Q2 13.5M $453M -$28.8M $33.49 131
2014 Q1 14.4M $501M -$54.9M $34.85 126